Zheng, Chuanxi
Fang, Jianguo
Wang, Yitian
Zhou, Yong
Tu, Chongqi
Funding for this research was provided by:
Key Programme (81702664)
Innovative Research Group Project of the National Natural Science Foundation of China (81801852)
Article History
Received: 16 October 2020
Accepted: 5 December 2020
First Online: 15 January 2021
Compliance with ethical standards
:
: The authors report no conflicts of interest in this work.
: This retrospective study was performed using data from anonymized patients who received apatinib treatment between October 2017 and January 2020. Because of the nature of retrospective design and patient anonymization, the ethical board of Sichuan University West China Hospital approved the retrospective study.
: Written informed consent of off-label treatment was obtained from all patients before treatment.